SEC Filing Details
Document Details
Form
Filing Date
Feb 16, 2022
Document Date
Dec 30, 2021
Form Description
Annual filing director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Denali Therapeutics
Issuer
Denali Therapeutics Inc.
Filer
Tessier-Lavigne Marc